675 related articles for article (PubMed ID: 37735472)
1. Targeting ferroptosis opens new avenues for the development of novel therapeutics.
Sun S; Shen J; Jiang J; Wang F; Min J
Signal Transduct Target Ther; 2023 Sep; 8(1):372. PubMed ID: 37735472
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic inhibition of ferroptosis in neurodegenerative disease.
Ryan SK; Ugalde CL; Rolland AS; Skidmore J; Devos D; Hammond TR
Trends Pharmacol Sci; 2023 Oct; 44(10):674-688. PubMed ID: 37657967
[TBL] [Abstract][Full Text] [Related]
3. Zooming in and out of ferroptosis in human disease.
Wang X; Zhou Y; Min J; Wang F
Front Med; 2023 Apr; 17(2):173-206. PubMed ID: 37121959
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic exploitation of ferroptosis.
Walravens M; Koeken I; Vanden Berghe T
Biochem Soc Trans; 2024 Apr; 52(2):693-706. PubMed ID: 38629629
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis: potential targets and emerging roles in pancreatic diseases.
Huang Z; Ma Y; Sun Z; Cheng L; Wang G
Arch Toxicol; 2024 Jan; 98(1):75-94. PubMed ID: 37934210
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases.
Wang Y; Li H; He Q; Zou R; Cai J; Zhang L
Apoptosis; 2024 Feb; 29(1-2):3-21. PubMed ID: 37848673
[TBL] [Abstract][Full Text] [Related]
7. Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology.
Wang Y; Tang B; Zhu J; Yu J; Hui J; Xia S; Ji J
Int J Biol Sci; 2022; 18(10):4260-4274. PubMed ID: 35844784
[TBL] [Abstract][Full Text] [Related]
8. An Overview of the Ferroptosis Hallmarks in Friedreich's Ataxia.
Turchi R; Faraonio R; Lettieri-Barbato D; Aquilano K
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33126466
[TBL] [Abstract][Full Text] [Related]
9. Role of GPX4 in ferroptosis and its pharmacological implication.
Seibt TM; Proneth B; Conrad M
Free Radic Biol Med; 2019 Mar; 133():144-152. PubMed ID: 30219704
[TBL] [Abstract][Full Text] [Related]
10. Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases.
Feng Q; Yang Y; Ren K; Qiao Y; Sun Z; Pan S; Liu F; Liu Y; Huo J; Liu D; Liu Z
Int J Biol Sci; 2023; 19(12):3726-3743. PubMed ID: 37564215
[TBL] [Abstract][Full Text] [Related]
11. The Application of Ferroptosis in Diseases.
Qiu Y; Cao Y; Cao W; Jia Y; Lu N
Pharmacol Res; 2020 Sep; 159():104919. PubMed ID: 32464324
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-Regulated Cell Death as a Therapeutic Strategy for Neurodegenerative Diseases: Current Status and Future Prospects.
Zhang JB; Jia X; Cao Q; Chen YT; Tong J; Lu GD; Li DJ; Han T; Zhuang CL; Wang P
ACS Chem Neurosci; 2023 Sep; 14(17):2995-3012. PubMed ID: 37579022
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis Is Regulated by Mitochondria in Neurodegenerative Diseases.
Zhou J; Jin Y; Lei Y; Liu T; Wan Z; Meng H; Wang H
Neurodegener Dis; 2020; 20(1):20-34. PubMed ID: 32814328
[TBL] [Abstract][Full Text] [Related]
14. The role of ferroptosis in neurodegenerative diseases.
Xu Y; Zhao J; Zhao Y; Zhou L; Qiao H; Xu Q; Liu Y
Mol Biol Rep; 2023 Feb; 50(2):1655-1661. PubMed ID: 36385663
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into ferroptosis: Implications for age-related diseases.
Zhou RP; Chen Y; Wei X; Yu B; Xiong ZG; Lu C; Hu W
Theranostics; 2020; 10(26):11976-11997. PubMed ID: 33204324
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis in neurodegenerative diseases: inhibitors as promising candidate mitigators.
Zhang RF; Zeng M; Lv N; Wang LM; Yang QY; Gan JL; Li HH; Yu B; Jiang XJ; Yang L
Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):46-65. PubMed ID: 36647850
[TBL] [Abstract][Full Text] [Related]
17. Targeting ferroptosis in neuroimmune and neurodegenerative disorders for the development of novel therapeutics.
Li Z; Zhang Y; Ji M; Wu C; Zhang Y; Ji S
Biomed Pharmacother; 2024 Jul; 176():116777. PubMed ID: 38795640
[TBL] [Abstract][Full Text] [Related]
18. Focus on ferroptosis regulation: Exploring novel mechanisms and applications of ferroptosis regulator.
Ma TL; Chen JX; Zhu P; Zhang CB; Zhou Y; Duan JX
Life Sci; 2022 Oct; 307():120868. PubMed ID: 35940216
[TBL] [Abstract][Full Text] [Related]
19. Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy.
Maru D; Hothi A; Bagariya C; Kumar A
Curr Cancer Drug Targets; 2022; 22(3):234-244. PubMed ID: 35152865
[TBL] [Abstract][Full Text] [Related]
20. FERREG: ferroptosis-based regulation of disease occurrence, progression and therapeutic response.
Zhou Y; Chen Z; Yang M; Chen F; Yin J; Zhang Y; Zhou X; Sun X; Ni Z; Chen L; Lv Q; Zhu F; Liu S
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38742521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
